243 related articles for article (PubMed ID: 35387124)
1. Biological Functions and Molecular Mechanisms of MiR-608 in Cancer.
Lu J; Zhu D; Li L
Front Oncol; 2022; 12():870983. PubMed ID: 35387124
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on the Expanding Role of miR-647 in Human Cancers.
Jalili M; Tavakoli S; Kargar K; Rafat M; Rad FR
Adv Biomed Res; 2023; 12():170. PubMed ID: 37564440
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers.
Zhou M; Wu Y; Li H; Zha X
J Cancer; 2020; 11(22):6716-6726. PubMed ID: 33046994
[TBL] [Abstract][Full Text] [Related]
4. The role and underlying mechanism of miR-1299 in cancer.
Kaiyuan D; Lijuan H; Xueyuan S; Yunhui Z
Future Sci OA; 2021 Mar; 7(6):FSO693. PubMed ID: 34046198
[TBL] [Abstract][Full Text] [Related]
5. MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer.
Liu X; He B; Xu T; Pan Y; Hu X; Chen X; Wang S
J Cancer; 2018; 9(7):1218-1230. PubMed ID: 29675103
[TBL] [Abstract][Full Text] [Related]
6. miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.
Bai H; Wu S
Onco Targets Ther; 2019; 12():11069-11082. PubMed ID: 31908476
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.
Cui J; Yuan Y; Shanmugam MK; Anbalagan D; Tan TZ; Sethi G; Kumar AP; Lim LHK
Int J Biol Sci; 2021; 17(15):4254-4270. PubMed ID: 34803496
[No Abstract] [Full Text] [Related]
8. MicroRNA-381-A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer.
Zeng X; Cao Z; Luo W; Zheng L; Zhang T
Front Oncol; 2020; 10():535665. PubMed ID: 33324542
[TBL] [Abstract][Full Text] [Related]
9. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.
Zhang J; Cao Z; Yang G; You L; Zhang T; Zhao Y
Front Oncol; 2019; 9():893. PubMed ID: 31572683
[TBL] [Abstract][Full Text] [Related]
11. MiR-643 Functions as a Potential Tumor Suppressor in Gastric Cancer by Inhibiting Cell Proliferation and Invasion
Wu Y; Ye H; Peng B; Jiang H; Tang Q; Liu Y; Xi J; Chen S
Ann Clin Lab Sci; 2021 Jul; 51(4):494-502. PubMed ID: 34452887
[TBL] [Abstract][Full Text] [Related]
12. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
13. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
Peng H; Pan X; Su Q; Zhu LS; Ma GD
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
16. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1.
Zhu Q; Li H; Li Y; Jiang L
Hum Cell; 2017 Oct; 30(4):290-299. PubMed ID: 28573504
[TBL] [Abstract][Full Text] [Related]
18. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Majid S; Dar AA; Saini S; Arora S; Shahryari V; Zaman MS; Chang I; Yamamura S; Tanaka Y; Deng G; Dahiya R
Cancer Res; 2012 Dec; 72(24):6435-46. PubMed ID: 23074286
[TBL] [Abstract][Full Text] [Related]
19. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers.
Khalili N; Nouri-Vaskeh M; Hasanpour Segherlou Z; Baghbanzadeh A; Halimi M; Rezaee H; Baradaran B
Life Sci; 2020 Sep; 256():117865. PubMed ID: 32502540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
